Literature DB >> 16087903

Blood harmane concentrations and dietary protein consumption in essential tremor.

E D Louis1, W Zheng, L Applegate, L Shi, P Factor-Litvak.   

Abstract

BACKGROUND: Beta-carboline alkaloids (e.g., harmane) are highly tremorogenic chemicals. Animal protein (meat) is the major dietary source of these alkaloids. The authors previously demonstrated that blood harmane concentrations were elevated in patients with essential tremor (ET) vs controls. Whether this difference is due to greater animal protein consumption by patients or their failure to metabolize harmane is unknown.
OBJECTIVE: The aim of this study was to determine whether patients with ET and controls differ with regard to 1) daily animal protein consumption and 2) the correlation between animal protein consumption and blood harmane concentration.
METHODS: Data on current diet were collected with a semiquantitative food frequency questionnaire and daily calories and consumption of animal protein and other food types was calculated. Blood harmane concentrations were log-transformed (logHA).
RESULTS: The mean logHA was higher in 106 patients than 161 controls (0.61 +/- 0.67 vs 0.43 +/- 0.72 g(-10)/mL, p = 0.035). Patients and controls consumed similar amounts of animal protein (50.2 +/- 19.6 vs 49.4 +/- 19.1 g/day, p = 0.74) and other food types (animal fat, carbohydrates, vegetable fat) and had similar caloric intakes. In controls, logHA was correlated with daily consumption of animal protein (r = 0.24, p = 0.003); in patients, there was no such correlation (r = -0.003, p = 0.98).
CONCLUSIONS: The similarity between patients and controls in daily animal protein consumption and the absence of the normal correlation between daily animal protein consumption and logHA in patients suggests that another factor (e.g., a metabolic defect) may be increasing blood harmane concentration in patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087903      PMCID: PMC4993192          DOI: 10.1212/01.wnl.0000172352.88359.2d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Detailed genotyping demonstrates association between the slow acetylator genotype for N-acetyltransferase 2 (NAT2) and familial Parkinson's disease.

Authors:  O Bandmann; J R Vaughan; P Holmans; C D Marsden; N W Wood
Journal:  Mov Disord       Date:  2000-01       Impact factor: 10.338

2.  Determination of harmane and harmine in human blood using reversed-phased high-performance liquid chromatography and fluorescence detection.

Authors:  W Zheng; S Wang; L F Barnes; Y Guan; E D Louis
Journal:  Anal Biochem       Date:  2000-03-15       Impact factor: 3.365

3.  Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease.

Authors:  J A Agúndez; F J Jiménez-Jiménez; A Luengo; J A Molina; M Ortí-Pareja; A Vázquez; F Ramos; J Duarte; F Coria; J M Ladero; J C Alvarez-Cermeño; J Benítez
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

4.  Does a screening questionnaire for essential tremor agree with the physician's examination?

Authors:  E D Louis; B Ford; H Lee; H Andrews
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

5.  An investigation on the central effects of harmine, harmaline and related beta-carbolines.

Authors:  J A Fuentes; V G Longo
Journal:  Neuropharmacology       Date:  1971-01       Impact factor: 5.250

6.  Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas.

Authors:  Naoko Ishibe; Rashmi Sinha; David W Hein; Martin Kulldorff; Paul Strickland; Adrian J Fretland; Wong-Ho Chow; Fred F Kadlubar; Nicholas P Lang; Nathaniel Rothman
Journal:  Pharmacogenetics       Date:  2002-03

7.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

8.  Harmaline-induced tremor: the benzodiazepine receptor as a site of action.

Authors:  H A Robertson
Journal:  Eur J Pharmacol       Date:  1980-10-03       Impact factor: 4.432

Review 9.  Exposure to beta-carbolines norharman and harman.

Authors:  W Pfau; K Skog
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-03-25       Impact factor: 3.205

10.  Cerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids.

Authors:  G Zetler; G Singbartl; L Schlosser
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

View more
  54 in total

1.  Reduced body mass index in essential tremor: a study of 382 cases and 392 matched controls.

Authors:  E D Louis; M Michalec
Journal:  Eur J Neurol       Date:  2014-11-04       Impact factor: 6.089

2.  Functional correlates of gait and balance difficulty in essential tremor: balance confidence, near misses and falls.

Authors:  Elan D Louis; Ashwini K Rao; Marina Gerbin
Journal:  Gait Posture       Date:  2011-09-18       Impact factor: 2.840

3.  Increased number of Purkinje cell dendritic swellings in essential tremor.

Authors:  M Yu; K Ma; P L Faust; L S Honig; E Cortés; J-P G Vonsattel; E D Louis
Journal:  Eur J Neurol       Date:  2011-12-05       Impact factor: 6.089

4.  Sleep in essential tremor: a comparison with normal controls and Parkinson's disease patients.

Authors:  Marina Gerbin; Amanda S Viner; Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2011-11-30       Impact factor: 4.891

5.  Utility of the hand-drawn spiral as a tool in clinical-epidemiological research on essential tremor: data from four essential tremor cohorts.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2015-02-17       Impact factor: 3.282

6.  Does age of onset in essential tremor have a bimodal distribution? Data from a tertiary referral setting and a population-based study.

Authors:  Elan D Louis; Okan Dogu
Journal:  Neuroepidemiology       Date:  2007-11-27       Impact factor: 3.282

7.  Triggering essential head tremor with sustained phonation: a clinical phenomenon with potential diagnostic value.

Authors:  Brenton A Wright; Monika Michalec; Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2013-11-12       Impact factor: 4.891

8.  Dietary epidemiology of essential tremor: meat consumption and meat cooking practices.

Authors:  Elan D Louis; Garrett A Keating; Kenneth T Bogen; Eileen Rios; Kathryn M Pellegrino; Pam Factor-Litvak
Journal:  Neuroepidemiology       Date:  2008-04-02       Impact factor: 3.282

9.  Subclinical tremor in normal controls with versus without a family history of essential tremor: data from the United States and Turkey.

Authors:  E D Louis; O Dogu; R Ottman
Journal:  Eur J Neurol       Date:  2009-11-24       Impact factor: 6.089

Review 10.  Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients.

Authors:  Elan D Louis; Rachel Babij; Karen Ma; Etty Cortés; Jean-Paul G Vonsattel
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.